the convergence of innovative therapy and allohct in aml
Published 1 year ago • 476 plays • Length 58:12Download video MP4
Download video MP3
Similar videos
-
1:33:16
the advantage of innovation in aml
-
59:18
multiple myeloma: the convergence of novel therapeutic platforms, cell therapy, and asct
-
55:01
oncology nurse perspectives, principles, and practice in an era of innovative aml therapies
-
1:57:53
unleashing the innovation era in aml
-
17:47
expert discussions on antibody-based therapy in aml
-
4:27
amneal leaders discuss crexont® approval
-
52:41
treating acute myeloid leukemia (aml) in older adults
-
1:09:02
webinar 6 - acute leukaemia cases
-
1:30:35
the precision team in aml
-
2:59
the prognostic and therapeutic implications of mrd in aml
-
3:41
mrd-guided therapy in patients with intermediate-risk aml compared to unguided cohort using psm
-
1:41:20
seizing opportunity in aml: realizing the potential of novel tx in diverse patient populations
-
59:42
progress in aml care: a clinical casebook on the intersection of novel therapy and allogeneic hct
-
42:18
advances in aml care: highlights from recent science
-
2:47
management of relapse following allohsct in patients with aml and mds
-
5:39
what are some of the challenges faced by patients with aml in complete remission?
-
23:04
tp53-mutant aml: a pathology-guided journey through diagnostic principles
-
1:40
the role of menin inhibitors in the treatment of aml
-
2:11
future prospects for car-t cell therapy in aml
-
5:18
revolutionizing aml treatment: innovative targeting approaches | guenther koehne, md, phd #aml
-
2:16
the importance of mrd in aml prognosis and therapy
-
1:31:39
modern aml therapy: precision and potent therapeutics